Cargando…
Estimating Change in Tremor Amplitude Using Clinical Ratings: Recommendations for Clinical Trials
Tremor rating scales are the standard method for assessing tremor severity and clinical change due to treatment or disease progression. However, ratings and their changes are difficult to interpret without knowing the relationship between ratings and tremor amplitude (displacement or angular rotatio...
Autor principal: | |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Columbia University Libraries/Information Services
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6802602/ https://www.ncbi.nlm.nih.gov/pubmed/31637097 http://dx.doi.org/10.7916/D89C8F3C |
_version_ | 1783460816956162048 |
---|---|
author | Elble, Rodger J. |
author_facet | Elble, Rodger J. |
author_sort | Elble, Rodger J. |
collection | PubMed |
description | Tremor rating scales are the standard method for assessing tremor severity and clinical change due to treatment or disease progression. However, ratings and their changes are difficult to interpret without knowing the relationship between ratings and tremor amplitude (displacement or angular rotation), and the computation of percentage change in ratings relative to baseline is misleading because of the ordinal nature of these scales. For example, a reduction in tremor from rating 2 to rating 1 (0–4 scale) should not be interpreted as a 50% reduction in tremor amplitude, nor should a reduction in rating 4 to rating 3 be interpreted as a 25% reduction in tremor. Studies from several laboratories have found a logarithmic relationship between tremor ratings R and tremor amplitude T, measured with a motion transducer: logT = α·R + β, where α ≈ 0.5, β ≈ –2, and log is base 10. This relationship is consistent with the Weber–Fechner law of psychophysics, and from this equation, the fractional change in tremor amplitude for a given change in clinical ratings is derived: (T(f)−T(i))/T(i)=10(α(R(f)−(R(i)))−1, where the subscripts i and f refer to the initial and final values. For a 0–4 scale and α = 0.5, a 1‐point reduction in tremor ratings is roughly a 68% reduction in tremor amplitude, regardless of the baseline tremor rating (e.g., 2 or 4). Similarly, a 2‐point reduction is roughly a 90% reduction in tremor amplitude. These Weber–Fechner equations should be used in clinical trials for computing and interpreting change in tremor, assessed with clinical ratings. |
format | Online Article Text |
id | pubmed-6802602 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | Columbia University Libraries/Information Services |
record_format | MEDLINE/PubMed |
spelling | pubmed-68026022019-10-21 Estimating Change in Tremor Amplitude Using Clinical Ratings: Recommendations for Clinical Trials Elble, Rodger J. Tremor Other Hyperkinet Mov (N Y) Viewpoints Tremor rating scales are the standard method for assessing tremor severity and clinical change due to treatment or disease progression. However, ratings and their changes are difficult to interpret without knowing the relationship between ratings and tremor amplitude (displacement or angular rotation), and the computation of percentage change in ratings relative to baseline is misleading because of the ordinal nature of these scales. For example, a reduction in tremor from rating 2 to rating 1 (0–4 scale) should not be interpreted as a 50% reduction in tremor amplitude, nor should a reduction in rating 4 to rating 3 be interpreted as a 25% reduction in tremor. Studies from several laboratories have found a logarithmic relationship between tremor ratings R and tremor amplitude T, measured with a motion transducer: logT = α·R + β, where α ≈ 0.5, β ≈ –2, and log is base 10. This relationship is consistent with the Weber–Fechner law of psychophysics, and from this equation, the fractional change in tremor amplitude for a given change in clinical ratings is derived: (T(f)−T(i))/T(i)=10(α(R(f)−(R(i)))−1, where the subscripts i and f refer to the initial and final values. For a 0–4 scale and α = 0.5, a 1‐point reduction in tremor ratings is roughly a 68% reduction in tremor amplitude, regardless of the baseline tremor rating (e.g., 2 or 4). Similarly, a 2‐point reduction is roughly a 90% reduction in tremor amplitude. These Weber–Fechner equations should be used in clinical trials for computing and interpreting change in tremor, assessed with clinical ratings. Columbia University Libraries/Information Services 2018-10-11 /pmc/articles/PMC6802602/ /pubmed/31637097 http://dx.doi.org/10.7916/D89C8F3C Text en © 2018 Elble. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution–Noncommerical–No Derivatives License, which permits the user to copy, distribute, and transmit the work provided that the original author and source are credited; that no commercial use is made of the work; and that the work is not altered or transformed. |
spellingShingle | Viewpoints Elble, Rodger J. Estimating Change in Tremor Amplitude Using Clinical Ratings: Recommendations for Clinical Trials |
title | Estimating Change in Tremor Amplitude Using Clinical Ratings: Recommendations for Clinical Trials |
title_full | Estimating Change in Tremor Amplitude Using Clinical Ratings: Recommendations for Clinical Trials |
title_fullStr | Estimating Change in Tremor Amplitude Using Clinical Ratings: Recommendations for Clinical Trials |
title_full_unstemmed | Estimating Change in Tremor Amplitude Using Clinical Ratings: Recommendations for Clinical Trials |
title_short | Estimating Change in Tremor Amplitude Using Clinical Ratings: Recommendations for Clinical Trials |
title_sort | estimating change in tremor amplitude using clinical ratings: recommendations for clinical trials |
topic | Viewpoints |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6802602/ https://www.ncbi.nlm.nih.gov/pubmed/31637097 http://dx.doi.org/10.7916/D89C8F3C |
work_keys_str_mv | AT elblerodgerj estimatingchangeintremoramplitudeusingclinicalratingsrecommendationsforclinicaltrials |